Trokendi XR is an extended-release form of topiramate, a prescription medication FDA-approved to treat epilepsy and prevent migraines. Unlike the immediate-release version (Topamax), which is taken twice daily, Trokendi XR is designed to be taken once a day. It’s approved for seizure treatment in patients 6 and older and for migraine prevention in patients 12 and older.
What Trokendi XR Treats
Trokendi XR has three FDA-approved uses. For epilepsy, it can serve as the sole treatment for partial-onset seizures or primary generalized tonic-clonic seizures in patients 6 and older. It can also be added to other seizure medications for those same seizure types, as well as for seizures associated with Lennox-Gastaut syndrome, a severe form of childhood epilepsy. Its third approved use is preventing migraines in patients 12 and older. It’s a preventive medication, meaning it reduces how often migraines occur rather than stopping one that’s already started.
How It Differs From Immediate-Release Topiramate
The key difference is how the drug enters your bloodstream. Immediate-release topiramate (Topamax) hits peak blood levels in about 1 hour and must be taken twice daily. Trokendi XR reaches peak levels in about 6 hours at steady state and is taken once daily. This slower absorption also means smoother drug levels throughout the day. In healthy subjects, Trokendi XR showed about 26% fluctuation in blood levels compared to 40% for immediate-release topiramate. Steadier drug levels can mean fewer peaks and valleys, which may reduce side effects for some people.
One practical tradeoff: Trokendi XR capsules must be swallowed whole. You cannot open them, sprinkle them on food, crush them, or chew them. If you can’t swallow capsules whole, this formulation isn’t an option. This is also why the medication is only recommended for children 6 and older.
How It Works in the Brain
The exact way topiramate controls seizures and prevents migraines isn’t fully understood, but it appears to work through several mechanisms at once. It calms overactive nerve signaling by blocking sodium channels, which are the electrical switches that neurons use to fire. It also boosts the activity of GABA, the brain’s main calming chemical, while dialing down glutamate, an excitatory chemical that can trigger seizures and migraine activity when levels run too high. On top of that, it inhibits certain enzymes involved in fluid and acid balance in the body, which contributes to both its effects and some of its side effects.
Common Side Effects
The side effect profile varies depending on what you’re taking it for and your age, but a few effects come up consistently across uses.
Tingling or numbness in the hands and feet (paresthesia) is the most frequently reported side effect. In migraine prevention trials, 51% of adults on topiramate experienced it compared to 6% on placebo. In epilepsy trials, 40% of adults on the higher dose reported it. This tingling is usually mild and often improves over time.
Weight loss and reduced appetite are common. In epilepsy monotherapy trials, 17% of adults on the treatment dose lost weight, and 14% reported decreased appetite. For migraine prevention, 9% lost weight and 15% had reduced appetite. This effect has led some prescribers to consider topiramate when a patient would benefit from weight reduction alongside seizure or migraine control.
Cognitive side effects are worth knowing about. In epilepsy adjunctive therapy trials, 13% of adults experienced psychomotor slowing, 13% had speech difficulties, and 29% reported drowsiness. In migraine trials, 7% reported memory difficulties. Some people describe this as a mental “fog” or trouble finding words. These effects tend to be more noticeable at higher doses and during the initial weeks of treatment.
Other commonly reported effects include dizziness, nausea, diarrhea, fatigue, and changes in taste. Children in epilepsy trials most often experienced drowsiness (26%) and fatigue (16%).
Serious Risks to Be Aware Of
Metabolic Acidosis
Topiramate can lower bicarbonate levels in the blood, making it more acidic than normal. This condition, called metabolic acidosis, can develop without obvious symptoms or cause faster breathing, fatigue, and loss of appetite. Over time, untreated acidosis can weaken bones and increase the risk of kidney stones. Baseline and periodic blood tests to check bicarbonate levels are recommended during treatment.
Eye Problems
A rare but serious reaction involves sudden onset of blurred vision, eye pain, and redness. This happens because topiramate can cause fluid shifts in the eye that lead to a type of acute glaucoma. Most cases occur within the first two weeks of starting the medication or within hours of a dose increase. Symptoms of sudden nearsightedness can appear within hours of taking a dose. If you experience sudden vision changes or eye pain, this requires immediate medical attention, as stopping the medication promptly typically resolves it.
Pregnancy Risks
Topiramate carries a significant risk of birth defects when taken during pregnancy. Infants exposed to topiramate during the first trimester had a 1.4% rate of oral clefts (cleft lip or palate), compared to 0.11% in unexposed infants. That translates to roughly a 12.5-fold increased risk. Data from the UK Epilepsy and Pregnancy Register found an even higher rate of 3.2% for oral clefts with topiramate monotherapy, about 16 times the background rate. Women of childbearing age should use effective contraception while on this medication.
Available Strengths
Trokendi XR comes in extended-release capsules at multiple strengths, allowing for gradual dose increases. Treatment typically starts at a low dose and is slowly increased over several weeks to reduce the likelihood of side effects. The target dose depends on whether you’re taking it for seizures or migraine prevention, your weight, and whether it’s being used alone or alongside other medications. Your prescriber will adjust the dose based on how you respond and what you can tolerate.